Dapagliflozin and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
Topic:
Heart Failure with Preserved Ejection Fraction (HFpEF)
Speaker:
Doctor J. Ostrominski (Boston, US)
Event:
Heart Failure 2023
Congress Presentation
About the speaker
Doctor John Ostrominski
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
0
follower
4 more presentations in this session
Access the full session
Heart failure with preserved ejection fraction (HFpEF) 3
Speakers:
Doctor J. Ostrominski, Doctor P. Palau Sampio, Ms A. Achten, Doctor M. Podolec, Mr J. Weerts
About the event
